HOME >> MEDICINE >> NEWS
MR spectroscopy significantly reduces need for breast biopsy

OAK BROOK, Ill.--In a study featured in the June issue of Radiology, researchers found that imaging suspicious breast lesions with magnetic resonance (MR) spectroscopy reduced the need for biopsy by 58 percent. The investigators, from Memorial Sloan-Kettering Cancer Center in New York, discovered that with the addition of MR spectroscopy to their breast MR imaging (MRI) protocol, 23 of 40 suspicious lesions could have been spared biopsy, and none of the resultant cancers would have been missed.

"All cancers in this study were identified with MR spectroscopy. There were no false-negative results," said Lia Bartella, M.D., lead investigator and assistant professor in the Department of Breast Imaging at Memorial Sloan-Kettering. "With the addition of MR spectroscopy to our breast MRI exam, we found that the number of biopsies recommended on the basis of MRI findings decreased significantly. These results should encourage more women to take this potentially life-saving test."

MRI is playing an increasingly important role in the screening of women at high risk for breast cancer. One drawback of the technology, however, has been a considerable number of breast biopsy procedures recommended on the basis of imaging findings, which turn out to be benign. With MR spectroscopy, the radiologist is able to see the chemical make-up of a tumor, so in most cases, he or she can tell without biopsy whether or not the lesion is cancerous.

"Breast tumors have elevated levels of choline compounds, which are a marker of an active tumor," Dr. Bartella said. "By performing a brief MR spectroscopy procedure after an MRI scan, which takes only 10 additional minutes, we can noninvasively see which tumors show elevated choline levels, and therefore which lesions are likely malignant. This eliminates the need for biopsy to find out what the tumor is made of."

In Dr. Bartella's study, 56 patients with 57 breast lesions underwent MRI first, followed by MR spectrosc
'"/>

Contact: Heather Babiar
hbabiar@rsna.org
630-590-7762
Radiological Society of North America
30-May-2006


Page: 1 2

Related medicine news :

1. High-tech spectroscopy may be used to monitor neuropsychiatric symptoms
2. 1.7m to build worlds first SIMS instrument combined with infra-red spectroscopy
3. MR spectroscopy helps identify cancerous breast tumors
4. MR spectroscopy may be superior for determining prostate cancer prognosis
5. Trial stops after stroke and mortality significantly reduced by blood
6. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
7. Full-term, low-birth-weight babies at significantly greater risk for early respiratory symptoms
8. Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
9. New study: Pine bark significantly reduces endometriosis
10. Regular acupressure can significantly reduce agitated behavior in dementia
11. Health care expenditures significantly higher for children with obesity

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: spectroscopy significantly reduces need for breast biopsy

(Date:11/21/2014)... Recently, TideStore.com, a leading online store offering ... special offer TideStore Thanksgiving Sales . According to ... now provided with big discounts. The special offer is ... an extra 10% discount with this coupon code: thanks. ... have opportunities to win free gifts. TideStore.com has done ...
(Date:11/21/2014)... November 21, 2014 TopConsumerReviews.com recently ... an industry leader in the relief of ... significant feelings of sadness and depression each year ... pharmaceutical choices. Often, prescription drugs can produce worse ... drugs are expensive and require regular follow-up visits ...
(Date:11/21/2014)... November 21, 2014 RankingBySEO has announced ... the online reputation of lawyers, and the company has ... announced the service for lawyers since it receives queries ... reputation in big numbers. So far, the company has ... law firms in different parts of the world, and ...
(Date:11/21/2014)... November 21, 2014 First Choice ... 7am today. The new facility is located at 225 ... , “We are pleased to join the Friendswood ... emergency medical care here,” said Dr. Siddiqi, Facility Medical ... , To celebrate the opening, First Choice Emergency Room ...
(Date:11/21/2014)... November 21, 2014 M3 Global Research ... healthcare professional panel, today announced two important leadership changes to ... DasGupta as President of Market Research, Americas and the promotion ... , Ms. DasGupta joined M3 in 2011 and ... recently Head of Sales. Roni has over 17 years ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Sales from TideStore.com 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
(Date:11/21/2014)... Depomed, Inc. (NASDAQ: DEPO ) today announced that it ... Healthcare Conference in New York City . ... 8:00 am EST (5:00 am PST) on Tuesday December 2, 2014.  ... via the Investor Relations page of the Depomed website at ... 30 days on the company,s website. About Depomed ...
(Date:11/21/2014)... Texas , Nov. 21, 2014  Lexicon Pharmaceuticals, ... pricing of its previously announced underwritten public offering of ... an effective shelf registration statement. The offering will consist ... offering price of $1.005 per share.  Lexicon has also ... to 7,462,687 additional shares of common stock.  All of ...
(Date:11/18/2014)... 18, 2014  Sanguine Biosciences – a biotechnology ... study recruitment – will use its proprietary mobile ... Pfizer Inc. find and recruit people diagnosed with ... members to participate in voluntary research, which will ... and hopefully aid in informing the development of ...
Breaking Medicine Technology:Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2
Cached News: